This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

PDF files are a necessary component of our multi-platform world. With this convenient file format, users are able to view and share documents across various devices, using various operating systems ...

As AI companies warn of the dangers of self-improving AI, a new report offers a rare look at how they’re working to make it a reality.

The last time I spoke about Recursion Pharmaceuticals (RXRX), it was with a Seeking Alpha article entitled "Recursion: "Hold" Rating Based On Initial REC-4881 FAP Treatment Data." With respect to this ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

RXRX is trading in the middle of its 52-week range and near its 200-day simple moving average. Price change The price of RXRX shares has increased $0.02 since the market last closed. This is a 0.57% ...

Salt Lake City, UT, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and ...

ESO is the European Organisation for Astronomical Research in the Southern Hemisphere. It operates the La Silla Paranal Observatory in Chile and has its headquarters in Garching, near Munich, Germany.

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

For the past few days I’ve been testing an impressive open-weight AI coding model called Flint. It suggests that fully recursive self-improvement, or RSI—an exciting and controversial approach that ...